1. Home
  2. FARO vs CDXC Comparison

FARO vs CDXC Comparison

Compare FARO & CDXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FARO
  • CDXC
  • Stock Information
  • Founded
  • FARO 1981
  • CDXC 1999
  • Country
  • FARO United States
  • CDXC United States
  • Employees
  • FARO N/A
  • CDXC N/A
  • Industry
  • FARO Industrial Machinery/Components
  • CDXC Medicinal Chemicals and Botanical Products
  • Sector
  • FARO Industrials
  • CDXC Health Care
  • Exchange
  • FARO Nasdaq
  • CDXC Nasdaq
  • Market Cap
  • FARO 517.4M
  • CDXC 572.6M
  • IPO Year
  • FARO 1997
  • CDXC N/A
  • Fundamental
  • Price
  • FARO $25.82
  • CDXC $5.37
  • Analyst Decision
  • FARO Strong Buy
  • CDXC Strong Buy
  • Analyst Count
  • FARO 2
  • CDXC 2
  • Target Price
  • FARO $29.50
  • CDXC $8.00
  • AVG Volume (30 Days)
  • FARO 173.0K
  • CDXC 712.2K
  • Earning Date
  • FARO 11-06-2024
  • CDXC 10-31-2024
  • Dividend Yield
  • FARO N/A
  • CDXC N/A
  • EPS Growth
  • FARO N/A
  • CDXC N/A
  • EPS
  • FARO N/A
  • CDXC 0.02
  • Revenue
  • FARO $347,732,000.00
  • CDXC $91,668,000.00
  • Revenue This Year
  • FARO N/A
  • CDXC $18.64
  • Revenue Next Year
  • FARO $3.99
  • CDXC $20.72
  • P/E Ratio
  • FARO N/A
  • CDXC $269.36
  • Revenue Growth
  • FARO N/A
  • CDXC 9.95
  • 52 Week Low
  • FARO $13.52
  • CDXC $1.36
  • 52 Week High
  • FARO $29.30
  • CDXC $7.97
  • Technical
  • Relative Strength Index (RSI)
  • FARO 48.69
  • CDXC 31.01
  • Support Level
  • FARO $24.95
  • CDXC $6.55
  • Resistance Level
  • FARO $28.21
  • CDXC $7.79
  • Average True Range (ATR)
  • FARO 1.16
  • CDXC 0.36
  • MACD
  • FARO -0.44
  • CDXC -0.24
  • Stochastic Oscillator
  • FARO 16.55
  • CDXC 1.75

About FARO FARO Technologies Inc.

Faro Technologies Inc is a technology company. It designs, develops, manufactures, markets and supports software-driven, three-dimensional (3-D) measurement, imaging, and realization solutions for the 3D metrology, architecture, engineering and construction (AEC), Operations and Maintenance (O&M) and public safety analytics markets. The company enables its customers to capture, measure, manipulate, interact with and share 3D and 2D data from the physical world in a virtual environment and then translate the information back into the physical domain. FARO suite of 3D products and software solutions are used for the inspection of components and assemblies, rapid prototyping, reverse engineering, documenting large volumes or structures in 3D, surveying, and construction.

About CDXC ChromaDex Corporation

ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.

Share on Social Networks: